← Back to Search

MedSMA℞T Mobile ED

Rockford, IL

N/A

Waitlist Available

Led By Olufunmilola Abraham, PhD

Research Sponsored by Olufunmilola Abraham

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

* Adults who receive an opioid prescription from a study Emergency Department,

* who report having an adolescent, aged 12-18, living at home,

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 3, 6, and 9 months.

Awards & highlights

No Placebo-Only Group

Summary

The goal of this clinical trial is to learn if a new smartphone-based intervention can help with factors related to opioid misuse in parents and adolescent/early adult children. The main question it aims to answer is: • Can this intervention improve knowledge of, and attitudes towards, opioid misuse over traditional opioid-related counseling alone? Participants will, in addition to receiving opioid counseling: * Join an online meeting with research staff to test the smartphone-based intervention * Report demographic information * Complete surveys about opioids * Complete a family medication safety plan * Complete surveys after 3, 6, and 9 months

See full description

Who is the study for?

This trial is for parents and their adolescent/early adult children who are dealing with opioid addiction. Participants must be willing to use a smartphone-based intervention, attend online meetings, provide demographic information, and complete various surveys about opioids over the course of 9 months.Check my eligibility

What is being tested?

The study is testing 'MedSMA℞T Mobile,' a new smartphone app designed to enhance traditional counseling for opioid misuse. It aims to see if using the app can improve knowledge and attitudes towards opioid misuse more effectively than counseling alone.See study design

What are the potential side effects?

Since this trial involves a behavioral intervention rather than medication, there are no direct side effects like those associated with drugs. However, participants may experience discomfort or emotional distress when discussing sensitive topics related to opioid misuse.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

* Adults who receive an opioid prescription from a study Emergency Department,

Select...

* who report having an adolescent, aged 12-18, living at home,

Select...

* who speak and understand English

Select...

* Each participant must have the ability to provide informed consent

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 3, 6, and 9 months.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 3, 6, and 9 months.

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 3, 6, and 9 months. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Change in Adolescent Opioid Safety and Learning (AOSL) scale score over 9 month study

Secondary study objectives

Change in Family Communication Behaviour Patterns over 9 months

Change in Medication Understanding and Use Self-Efficacy (MUSE) scale scores over 9 months

Change in Opioid Disposal Behaviour over 9 months

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment1 Intervention

This group will receive the intervention of interest, MedSMA℞T Mobile, in addition to standard opioid-related counseling. MedSMA℞T Mobile is a serious game (intended to educate while entertaining) focused on opioid safety.

Group II: ControlActive Control1 Intervention

This group will receive the standard opioid-related counseling that all patients receive when newly prescribed opioids in the emergency department.

0 / 4Eligibility criteria met